Interleukin-1β-induced, nitric oxide-dependent and -independent inhibition of vascular smooth muscle contraction

European Journal of Pharmacology

Volumn 330, Issue 2-3, 1997, Pages 143-150

  Takizawa, Satoko ^a   Ozaki, Hiroshi ^a   Karaki, Hideaki ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Aorta; CGMP; Nitric oxide (NO) synthase; Rat; Relaxation

Indexed keywords

8 BROMO CYCLIC GMP; AMINOGUANIDINE; CYCLIC GMP; INTERLEUKIN 1BETA; METHYLENE BLUE; N(G) METHYLARGININE; NITRIC OXIDE; NITROPRUSSIDE SODIUM; PHENYLEPHRINE; TETRYLAMMONIUM; ENZYME INHIBITOR; INTERLEUKIN 1; POTASSIUM CHLORIDE; VASODILATOR AGENT;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DESENSITIZATION; DOSE TIME EFFECT RELATION; IN VITRO STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; VASCULAR SMOOTH MUSCLE; VASOCONSTRICTION; ANIMAL; CELL MEMBRANE POTENTIAL; DRUG EFFECT; METABOLISM; MUSCLE CONTRACTION; PHYSIOLOGY; THORACIC AORTA; VASODILATATION; WISTAR RAT;

ANIMALS; AORTA, THORACIC; CYCLIC GMP; ENZYME INHIBITORS; INTERLEUKIN-1; MALE; MEMBRANE POTENTIALS; MUSCLE CONTRACTION; MUSCLE, SMOOTH, VASCULAR; NITRIC OXIDE; NITROPRUSSIDE; OMEGA-N-METHYLARGININE; POTASSIUM CHLORIDE; RATS; RATS, WISTAR; VASODILATION; VASODILATOR AGENTS;

EID: 0030610555     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(97)00164-7     Document Type: Article

References (30)

1. Beasley D., McGuiggin M. Interleukin 1 activates soluble guanylate cyclase in human vascular smooth muscle cells through a novel nitric oxide-independent pathway. J. Exp. Med. 179:1994;71.
2. Beasley D.R., Cohen A., Levinsky N.G. Interleukin 1 inhibits contraction of vascular smooth muscle. J. Clin. Invest. 83:1989;331.
3. Beasley D., Schwartz J.H., Brenner B.M. Interleukin 1 induces prolonged L-arginine-dependent cyclic guanosine monophosphate and nitrite production in rat vascular smooth muscle cells. J. Clin. Invest. 87:1991;602.
4. Bolotina V.M., Najibi S., Palacino J.J., Pagano P.J., Cohen R.A. Nitric oxide directly activates calcium-dependent potassium channels in vascular smooth muscle. Nature. 368:1994;850.
5. Busse R., Mulsch A. Induction of nitric oxide synthase by cytokines in vascular smooth muscle cells. FEBS Lett. 275:1990;87.
6. Casey L.C., Balk R.A., Bone R.C. Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome. Ann. Intern. Med. 119:1993;771.
7. De Kimpe S.J., Van Heuven-Nolsen D., Van Amsterdam J.G.C., Radomski M.W., Nijkamp F.P. Induction of nitric oxide release by interferon-γ inhibits vasodilation and cyclic GMP increase in bovine isolated mesenteric arteries. J. Pharmacol. Exp. Ther. 268:1994;910.
8. Dinarello C.A. Biology of interleukin 1. FASEB J. 2:1988;108.
9. Evans T., Carpenter A., Silva A., Cohen J. Inhibition of nitric synthase in experimental gram-negative sepsis. J. Infect. Dis. 169:1994;343.
10. French J.F., Lambert L.E., Dage R.C. Nitric oxide synthase inhibitors inhibit interleukin-1β-induced depression of vascular smooth muscle. J. Pharmacol. Exp. Ther. 259:1991;260.
11. Fullerton D.A., McIntyre R.C. Jr., Hahn A.R., Agrafojo J., Koike K., Meng X., Banerjee A., Harken A.H. Dysfunction of cGMP-mediated pulmonary vasorelaxation in endotoxin-induced acute lung injury. Am. J. Physiol. 268:1995;L1029.
12. Griscavage J.M., Rogers N.E., Sherman M.P., Ignarro L.J. Inducible nitric oxide synthase from a rat alveolar macrophage cell line is inhibited by nitric oxide. J. Immunol. 151:1993;6329.
13. Ignarro L.J., Lippton H., Edwards J.C., Baricos W.H., Hyman A.L., Kodowitz P.J., Gruetter C.A. Mechanism of vascular smooth muscle relaxation by organic nitrates nitrites, nitroprusside and nitric oxide: evidence for the involvement of S-nitrosothiols as active intermediates. J. Pharmacol. Exp. Ther. 218:1981;739.
14. Janis R.A., Diamond J. Relationship between cyclic nucleotide levels and drug-induced relaxation of smooth muscle. J. Pharmacol. Exp. Ther. 211:1979;480.
15. Kanno K., Hirata Y., Imai T., Marumo F. Induction of nitric oxide synthase gene by interleukin in vascular smooth muscle cells. Hypertension. 22:1993;34.
16. Karaki H., Sato K., Ozaki H., Murakami K. Effects of sodium nitroprusside on cytosolic calcium level in vascular smooth muscle. Eur. J. Pharmacol. 156:1988;259.
17. Misko T.P., Schilling R.J, Salvemini D., Moore W.M., Currie M.G.A. Fluorometric assay for the measurements of nitrite in biological samples. Anal. Biochem. 214:1993;11.
18. Nakaki T., Otsuka Y., Nakayama M., Kato R. Endothelium-accelerated hyporesponsiveness of norepinephrine-elicited contraction of rat aorta in the presence of bacterial lipopolysaccharide. Eur. J. Pharmacol. 219:1992;311.
19. Nava E., Palmer R.M.J., Moncada S. Inhibition of nitric oxide synthesis in septic shock: how much is beneficial? Lancet. 338:1991;1555.
20. Nishio M., Kigoshi S., Muramatsu I. Mechanisms of tetraethylammonium induced contraction in the canine coronary artery. Pharmacology. 33:1986;256.
21. Okusawa S.J., Gelfand A., Ikejima T., Connolly R.J., Dinarello C.A. Interleukin 1 induces a shock-like state in rabbits: synergism with tumor necrosis factor and the effect of cyclooxygenase inhibitor. J. Clin. Invest. 81:1988;1162.
22. Papapetropoulos A., Abou-Mohamed G., Marczin N., Murad F., Caldwell R.W., Catravas J.D. Downregulation of nitrovasodilator-induced cyclic GMP accumulation in cells exposed to endotoxin or interleukin-1β Br. J. Pharmacol. 118:1996;1359.
23. Petros A., Bennett D., Vallance P. Effect of nitric oxide synthase inhibitors on hypotension in patients with septic shock. Lancet. 338:1991;1557.
24. Shultz K.D., Schultz K., Schultz G. Sodium nitroprusside and other smooth muscle-relaxants increase cyclic GMP levels in rat ductus deferens. Nature. 265:1977;750.
25. Tsuchida S., Hiraoka M., Sudo M., Kigoshi S., Muramatsu I. Attenuation of sodium nitroprusside responses after prolonged incubation of rat aorta with endotoxin. Am. J. Physiol. 267:1994;H2305.
26. Wang P., Zheng F.B., Chaudry I.H. Nitric oxide: to block or enhance its production during sepsis? Arch. Surg. 129:1994;1137.
27. Wei X.Q., Charles I.G., Smith A., Ure J., Feng G.J., Huang F.P., Damo X., Muller W., Moncada S., Liew F.Y. Altered immune responses in mice lacking inducible nitric oxide synthase. Nature. 375:1995;408.
28. Wiersma J.H. 2,3-Diaminonaphthalene as a spectrometric and fluorometric reagent for the determination of nitrite ion. Anal. Lett. 3:1970;123.
29. Wolfe T.A., Dasta J.F. Use of nitric oxide synthase inhibitors as a novel treatment for septic shock. Ann. Pharmacother. 29:1995;36.
30. Wu C.C., Szab C., Chen S.J., Thiemermann C., Vane J.R. Activation of soluble guanylate cyclase by a factor other than nitric oxide or carbon monoxide contributes to the vascular hyporeactivity to vasoconstrictor agents in the aorta of rats treated with endotoxin. Biochem. Biophys. Res. Commun. 201:1994;436.